Kniewska I, Hołowiecki J, Krykowski E, Rudzka E, Krzemień S, Krawczyk M, Duraj M, Brodowski L, Urbańska-Ryś H
Pol Tyg Lek. 1989;44(40-42):872-4.
Aspiration biopsy in 31 patients with AML was performed prior to and in the 6th day of induction therapy. Studied group included 17 women and 14 men of 40 yrs mean age. Blastosis prior to and on the 6th day of the observation were compared and the index of blastosis reduction counted. Median value of blastosis reduction was 29.5%, 40% of the patients with the index below the median value showed complete remission, while the patients with the indexes above the median value obtained significantly higher number of complete remission (CR = 81%, p less than 0.05). Statistically significant reduction of leukaemic infiltration in examined myelograms was as s rule the sign of oncoming favourable therapeutic result. In cases of nonaplastic marrow with persistent blastosis (blastosis reduction 29.5%) one should consider a change of the therapeutic regimen.
对31例急性髓系白血病患者在诱导治疗前及治疗第6天进行了穿刺活检。研究组包括17名女性和14名男性,平均年龄40岁。比较了观察前和第6天的原始细胞数,并计算原始细胞减少指数。原始细胞减少的中位数为29.5%,指数低于中位数的患者中有40%实现了完全缓解,而指数高于中位数的患者获得完全缓解的比例显著更高(完全缓解率=81%,p<0.05)。在检查的骨髓图中,白血病浸润的统计学显著减少通常是即将出现良好治疗效果的标志。在非再生障碍性骨髓且原始细胞持续存在(原始细胞减少<29.5%)的情况下,应考虑改变治疗方案。